357 related articles for article (PubMed ID: 14111253)
1. [HORMONAL TREATMENT OF THREATENED ABORTION].
BRUNO RO
Sem Med; 1963 Nov; 123():1701-7. PubMed ID: 14111253
[No Abstract] [Full Text] [Related]
2. [ENDOCRINE ASPECTS OF ABORTION].
BOTELLA-LLUSIA J
Rev Fr Endocrinol Clin; 1963; 4():397-408. PubMed ID: 14091647
[No Abstract] [Full Text] [Related]
3. [THEORETICAL CHARACTERISTICS OF CHORIONIC GONADOTROPIN THERAPY AND ITS USE IN THREATENED ABORTION].
NYIRI I; TAKACS I
Zentralbl Gynakol; 1964 Jul; 86():990-7. PubMed ID: 14253030
[No Abstract] [Full Text] [Related]
4. CYTOLOGICAL OBSERVATIONS, CERVICAL MUCUS "FERNING" AND HORMONE ASSAYS IN EARLY PREGNANCY.
HUGHES HE; LORAINE JA; BELL ET; LAYTON R
Am J Obstet Gynecol; 1964 Dec; 90():1297-303. PubMed ID: 14233689
[No Abstract] [Full Text] [Related]
5. A COMPARISON BETWEEN VAGINAL CYTOLOGY AND URINARY HORMONE EXCRETION DURING PREGNANCY.
MACRAE DJ; IRANI JB; BOWLER RG; LONGHURST PL
J Obstet Gynaecol Br Commonw; 1964 Aug; 71():586-98. PubMed ID: 14194445
[No Abstract] [Full Text] [Related]
6. The value of urinary pregnanediol determinations as an indication for the use of progesterone in the treatment of threatened abortion.
BAKER WS; BANCROFT CE; LYDA EW; LEHMAN JJ
Am J Obstet Gynecol; 1955 Feb; 69(2):405-14. PubMed ID: 13228513
[No Abstract] [Full Text] [Related]
7. Urinary excretion of pregnanediol after intravenous administration of progesterone in threatened abortion.
BARNES LW
Am J Obstet Gynecol; 1958 Jan; 75(1):53-9. PubMed ID: 13487681
[No Abstract] [Full Text] [Related]
8. THE EFFECT OF TREATMENT OF ABORTION-PRONE WOMEN WITH SECROSTERON AND PROVERA.
Krieger VI
Aust N Z J Obstet Gynaecol; 1963 Sep; 3(3):129-31. PubMed ID: 14065030
[No Abstract] [Full Text] [Related]
9. PREGNANEDIOL EXCRETION AND SEX OF THE FETUS.
RAWLINGS WJ; KRIEGER VI
Fertil Steril; 1964; 15():173-9. PubMed ID: 14126770
[No Abstract] [Full Text] [Related]
10. [Etiologic hormonal factors in abortion].
Jayle MF
Rev Fr Endocrinol Clin; 1967; 8(6):467-78. PubMed ID: 5627347
[No Abstract] [Full Text] [Related]
11. Hormone excretion in hormone-induced pregnancy.
Crooke AC; Butt WR; Bertrand PV; el-Nahas HZ; Hansotia MD; Morris R
Proc R Soc Med; 1970 Nov; 63(11 Part 1):1100. PubMed ID: 5484924
[No Abstract] [Full Text] [Related]
12. [The current status of progestational hormone therapy].
NICCOLO M
Quad Clin Ostet Ginecol; 1962 Nov; 17():826-30. PubMed ID: 13938314
[No Abstract] [Full Text] [Related]
13. THE MANAGEMENT OF THREATENED ABORTION BY PREGNANEDIOL ESTIMATION AND VAGINAL CYTOLOGY.
Cox LW; Cox RI; Skipper JS
Aust N Z J Obstet Gynaecol; 1964 Dec; 4(4):160-4. PubMed ID: 14243039
[No Abstract] [Full Text] [Related]
14. [THE PROGESTATIONAL STEROIDS].
SARGO LF
Sem Med; 1963 Aug; 123():379-91. PubMed ID: 14092024
[No Abstract] [Full Text] [Related]
15. URINARY HORMONE EXCRETION IN ABNORMAL PREGNANCY.
BOOTH RT; STERN MI; WOOD C; SHARPLES MJ; PINKERTON JH
J Obstet Gynaecol Br Commonw; 1965 Apr; 72():229-35. PubMed ID: 14273101
[No Abstract] [Full Text] [Related]
16. ABORTIONS AND MISCARRIAGES.
WINTERTON WR
Practitioner; 1964 Feb; 192():222-8. PubMed ID: 14122916
[No Abstract] [Full Text] [Related]
17. PREGNANEDIOL EXCRETION AND PLACENTAL INSUFFICIENCY.
RAWLINGS WJ
Fertil Steril; 1965; 16():323-36. PubMed ID: 14285363
[No Abstract] [Full Text] [Related]
18. ENDOMETRIAL SCLEROSIS.
GIBBS CE
JAMA; 1964 Apr; 188():390-1. PubMed ID: 14114030
[No Abstract] [Full Text] [Related]
19. [On the problem of the treatment of threatened habitual abortion].
BARNAGIAN-GADZIEVA AM
Sov Med; 1960 Feb; 24():91-4. PubMed ID: 13796846
[No Abstract] [Full Text] [Related]
20. Threatened abortion; an evaluation of the prognosis based on pregnanediol determinations and of treatment with progesterone.
KOFF AK; TULSKY AS
Surg Clin North Am; 1953 Feb; ():3-15. PubMed ID: 13015384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
